We would love to hear your thoughts about our site and services, please take our survey here.
Shuggy please remind us of the percentage held by the LSE board.
19.1% with the pubic and I know where nearly 10% of that is and it's sticky. Real free float is only ~9-10%, grab yours while you can!
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/lse-hemo/hemogenyx-pharmaceuticals-shares
Check sections 9.3 and 9.4. only 19.1% belonging to the public. Look at that list of institutions already invested in HEMO.
The free float is very small on HEMO and the shares are sticky with very low levels of selling. The price is rising get your shares before it's too late. MMs are more than happy letting this rise now even on low volume where we usually trickle down.
Don't be the one left panic buying on news day at 30p! And more importantly don't be a Pumpky!!
I'm still here too waiting patiently. My family now have 5m shares and family friends with 500k. Good things are coming I know that, without a shadow of a doubt the Lilly deal will be done.
The downtrend had reversed and we're on the way up, expecting gains as we draw closer to the Lilly deal deadline.
I think we should already be stable at 15p when the Lilly deal is done stable at 30-40p
Hah I always thought you are Mrs Houbs..
Davie, I'm with HL too. Give them a call and they'll sort it for you. Or send them a secured message.
I have given all of my, my family and family friends votes to the chair of the meeting. I recommend everyone else does the same or votes to pass all the resolutions.
Would be crazy to vote no and take a pass on this financing opportunity.
Big things are coming for HEMO, and cash in the bank only helps those things come faster!
Sadly all great investments attract some great idiots, but they are a tiny minority compared to the real well read investors.
This great opportunity we have in hemogenyx will some through in 2021 as 3 products move into clinical trials. We now have funding to secure our direction and pace, will only makes collaborators more eager.
Henogenyx will continue to grow their portfolio on product candidates, the methods they are working on can be transferred to other types of blood cancers, possibly by the end of 2021 Vlad has over 10 product candidates.
Validation of this company is on the way and there are great rewards coming for shareholders. My 4.5m shares are staying right where they are.
I know that I am no longer the LSE highest holder of HEMO. There is someone with way more shares than I have, but I shall not name names until they wish to reveal themselves!
Big chuck that could be added to your list ;)
Hey Shuggy, you can put me at 4.5m and my friends and family to 500k for the next edition
https://doi.org/10.1182/blood-2020-142709
https://doi.org/10.1182/blood-2020-142745
Group!?
I think we see on this board lots of emotion as this share could grow massively, and some people are here on a spike near 15p.
When things are going good we have a supportive community all declaring their holdings, and when things are bad we see arguing.
I'm someone with a very over extended and extremely risky position. Stay strong and retain your holding until we see the CDX news, years of great hard work is about to be commercialized.
Some of us have a clue Shuggy, UP!
Very high up
I can't say this enough, buy your seat and sit back. Chad booked out an entire row.
Hemo on the verge of a huge commercial deal.
Monster deal incoming, pay for your seat and sit back. 2021 will see CDX and CART move into clinical trials and multiples of the current SP.
Scoote let me assure you that it will not get to 6-7p. Because if it gets even close to that I will liquidate physical assets to buy a few million additional shares
It's not spikey you're just seeing the difference between buy and sell with a spread of 0.3p. but the selling price is slowly rising
I think Vlad means that he and the team are not just waiting around to become successful, they are doing good work.